SHENZHEN HEPALINK PHARMACEUTICAL earnings per share and revenue

9989 earnings per share for the last quarter are -0.10 HKD whereas the estimation was -0.12 HKD which accounts for 18.11% surprise. Company revenue for the same period amounts to 1.29 B HKD despite the estimated figure of 1.32 B HKD. Estimated earnings per share for the next quarter are 0.11 HKD, and revenue is expected to reach 1.23 B HKD. Also watch annual changes over time to get a bigger picture of 9989 earnings per share and revenue dynamics.